The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel.
The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.
Ann Clin Transl Neurol. 2021 Jun;8(6):1260-1268. doi: 10.1002/acn3.51362. Epub 2021 May 11.
Mutations in the HSPB1 gene are associated with a distal hereditary motor neuropathy type 2 (dHMN2) or Charcot-Marie-Tooth disease type 2F (CMT2F), usually with autosomal dominant inheritance. This study aimed to describe the phenotype of the HSPB1 c.407G>T (p.Arg136Leu) mutation at early and late stages of the disease course.
We identified this mutation (previously reported in patients from Italy) in a heterozygous state, among 14 individuals from eight families of Jewish Iranian descent. The clinical, electrophysiological and ultrasonographic features were evaluated during early (less than 5 years, N = 9) or late disease course (N = 5).
The majority of subjects were males with a mean age at onset of 43.4 years (range 21-67). Common initial symptoms were gait imbalance, distal (often asymmetric) lower limb weakness and feet numbness. Neurological examination in early disease course showed distal lower extremity weakness in nearly all cases, and absent Achilles tendon reflex in about half. A minority had distal loss of pain, vibration or position sensation. These findings were more prevalent in late disease stage. Electrodiagnostic studies demonstrated a length-dependent axonal motor neuropathy, with typical preferential involvement of the tibial nerve. Muscle ultrasound showed a corresponding length-dependent increase of homogeneous echo-intensity, most noticeably in the gastrocnemius. One patient had a dual diagnosis of CMT2F and CMT2W.
The HSPB1 c.407G>G (p.Arg136Leu) mutation causes an adult-onset, predominantly motor, axonal neuropathy in individuals of Jewish Iranian descent. Variable manifestations are noticed, and sensory involvement is more prominent in prolonged disease duration.
HSPB1 基因突变与远端遗传性运动神经病 2 型(dHMN2)或 Charcot-Marie-Tooth 病 2F 型(CMT2F)相关,通常呈常染色体显性遗传。本研究旨在描述 HSPB1 c.407G>T(p.Arg136Leu)突变在疾病早、晚期的表型。
我们在 8 个有犹太伊朗血统的家系的 14 名杂合子个体中发现了该突变(先前在意大利患者中报道过)。在疾病早期(<5 年,N=9)或晚期(N=5)评估了临床、电生理和超声特征。
大多数患者为男性,发病年龄的平均值为 43.4 岁(范围 21-67 岁)。常见的首发症状为步态不稳、远端(常为不对称)下肢无力和足部麻木。在疾病早期,神经系统检查几乎所有病例均表现为下肢远端无力,近半数病例跟腱反射消失。少数患者有远端痛觉、震动觉或位置觉丧失。这些表现在疾病晚期更为常见。电诊断研究显示存在长度依赖性轴索性运动神经病,典型表现为胫神经的优先受累。肌肉超声显示相应的长度依赖性均匀回声强度增加,最明显的是在腓肠肌。1 名患者同时诊断为 CMT2F 和 CMT2W。
HSPB1 c.407G>T(p.Arg136Leu)突变导致以成年起病、主要为运动性、轴索性神经病的个体发生犹太伊朗血统人群中的疾病。表现存在变异性,且感觉受累在疾病持续时间较长时更为突出。